Furthermore, in a recent experimental setup, MTX and oral bactericidal and antibiotic treatments were found comparable in their amelioration of alveolar bone loss, with MTX also efficiently decreasing serum levels of receptor activator of NF-κB ligand (RANKL) in RA-patients49,50. Here, TNFSF11 is linked to rheumatoid arthritis.